Breaking News
Sort by:
Date
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New Collaboration Between NICE and AHSN will Help Embed Innovations into the Healthcare System for the Benefit of Patients
NICE and the Academic Health Science Network (AHSN) have today (4 August) announced a two-year […]
New Drug Combo for Advanced Breast Cancer Approved for NHS in England
The National Institute of Health and Care Excellence (NICE) has approved the use of a […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more